Thiel-Linked HHS Nominee Threatens MAHA Ambitions with Biotech Stance
Biotech investor and Peter Thiel associate Jim O’Neill, a candidate for a position at HHS, is poised to usher in a deregulatory paradigm that would allow a proliferation of dubious products on the US market under the guise of “innovation” and “efficiency.” Late last November, President Donald Trump announced Jim O’Neill as his nominee for […]